• 1
    Bréchot C, Pol S. Hepatitis C virus biology and genetic variability: implications for the management of infected patients. In: BoyerJ, OcknerRC, eds. Progress in Liver Diseases. Philadelphia: Saunders, 1998;183217.
  • 2
    Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993; 67:38353844. MEDLINE
  • 3
    Grakoui A, Wychowski C, Lin C, Feinstone S, Rice C. Expression and identification of hepatitis C virus polyprotein. J Virol 1993; 67:13851395. MEDLINE
  • 4
    Selby M, Choo Q, Berger K, Kuo G, Glazer E, Eckart M, Lee C, et al. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993; 74:11031113. MEDLINE
  • 5
    Alter MJH. Epidemiology of hepatitis C. Hepatology 1997; 26:6265.
  • 6
    Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995; 15:6469. MEDLINE
  • 7
    McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional therapy group. N Engl J Med 1998; 339:14851492. MEDLINE
  • 8
    McHutchinson JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19:5765. MEDLINE
  • 9
    Schalm SW, Weiland O, Hansen BE, Milella M, Lai MY, Hollander A, Michielsen PP, et al. Interferon-ribavirin for chronic hepatitis C with or without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep study group for viral hepatitis. Gastroenterology 1999; 117:408413. MEDLINE
  • 10
    Gale MJ, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Korth MJ, Polyak SJ, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanism of kinase regulation. Mol Cell Biol 1998; 18:52085218. MEDLINE
  • 11
    Polyak SJ, Paschal DM, McArdle S, Gale MJ, Jr, Moradpour D, Gretch DR. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 1999; 29:12621271. MEDLINE
  • 12
    Heim MH, Moradpour D, Blum HE. Expression of Hepatitis C Virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 1999; 73:84698475. MEDLINE
  • 13
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96:224230. MEDLINE
  • 14
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334:7781. MEDLINE
  • 15
    Hofgartner W, Polyak SJ, Sullivan D, Carithers RLJ, Gretch DR. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 1997; 53:118126. MEDLINE
  • 16
    Khorsi H, Castelain S, Wyseur A, Izopet J, Canva A, Rombout D, Capron D, et al. Mutations in hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients. J Hepatol 1997; 27:7277. MEDLINE
  • 17
    Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 1998; 72:27952805. MEDLINE
  • 18
    Rispeter K, Lu M, Zibert A, de Olivera JM, Roggendorf M. The “interferon sensitivity determining region” of hepatitis C virus is a stable sequence element. J Hepatol 1998; 29:352361. MEDLINE
  • 19
    Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 1997; 113:567572. MEDLINE
  • 20
    Squadrito G, Orlando ME, Cacciola I, Rumi MG, Artini M, Picciotto A, Loiacono O, et al. Long-term response to interferon alpha is unrelated to “interferon sensitivity determining region” variability in patients with chronic hepatitis C virus-1b infection. J Hepatol 1999; 30:10231027. MEDLINE
  • 21
    Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 1997; 25:740744. MEDLINE
  • 22
    Duverlie G, Khorsi H, Castelain S, Jaillon O, Izopet J, Lunel F, Eb F, et al. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol 1998; 79:13731381. MEDLINE
  • 23
    Song J, Fujii M, Wang F, Itoh M, Hotta H. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J Gen Virol 1999; 80:879886. MEDLINE
  • 24
    Kaufman RJ. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc Natl Acad Sci U S A 1999; 96:1169311695. MEDLINE
  • 25
    Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997; 230:217227. MEDLINE
  • 26
    Gale MJ, Kwieciszewski B, Dossett M, Nakao H, Katze MG. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999; 73:65066516. MEDLINE
  • 27
    Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999; 80:11791183. MEDLINE
  • 28
    Fukuma T, Enomoto N, Marumo F, Sato C. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Hepatology 1998; 28:11471153. MEDLINE
  • 29
    Tanimoto A, Ide Y, Arima N, Sasaguri Y, Padmanabhan R. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochem Biophys Res Commun 1997; 236:360364. MEDLINE
  • 30
    Tan WL, Nakao H, He Y, Vijayri S, Neddermann P, Jacobs B, Mayer BJ, et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in an src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 1999; 96:55335538. MEDLINE
  • 31
    Chung KM, Lee J, Kim JE, Song OK, Cho S, Lim J, Seedorf M, et al. Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin 3. J Virol 2000; 74:52335241. MEDLINE
  • 32
    Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A non-B hepatitis. Proc Natl Acad Sci U S A 1990; 87:95249528. MEDLINE
  • 33
    Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 1983; 302:3337. MEDLINE
  • 34
    Moradpour D, Kary P, Rice CM, Blum HE. Continous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 1998; 28:192201. MEDLINE
  • 35
    Lu J, O'Hara EB, Trieselmann BA, Romano PR, Dever TE. The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2 alpha. J Biol Chem 1999; 274:3219831203. MEDLINE
  • 36
    Paterson M, Laxton CD, Thomas HC, Ackrill AM, Foster GR. Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with the clinical response. Gastroenterology 1999; 117:11871197. MEDLINE
  • 37
    Francois C, Duverlie G, Rebouillat D, Khorsi H, Castelain S, Blum HE, Gatignol A, et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 2000; 74:55875596. MEDLINE
  • 38
    Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:19721974. MEDLINE
  • 39
    Polyak SJ, Khabar KSK, Paschal DM, Ezelle H, Barber GN, Levy DE, Mukaida N, et al. A novel mechanism of hepatitis C virus interferon resistance: induction of expression of the CXC chemokine, interleukine-8, by the non-structural 5A protein [Abstract]. Hepatology 2000;32:A 553.